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Abstract
Background: Human diseases are commonly the result of multidimensional changes at molecular, cellular, and
systemic levels. Recent advances in genomic technologies have enabled an outpour of omics datasets that capture
these changes. However, separate analyses of these various data only provide fragmented understanding and do
not capture the holistic view of disease mechanisms. To meet the urgent needs for tools that effectively integrate
multiple types of omics data to derive biological insights, we have developed Mergeomics, a computational
pipeline that integrates multidimensional disease association data with functional genomics and molecular
networks to retrieve biological pathways, gene networks, and central regulators critical for disease development.
Results: To make the Mergeomics pipeline available to a wider research community, we have implemented an
online, user-friendly web server (http://mergeomics.research.idre.ucla.edu/). The web server features a modular
implementation of the Mergeomics pipeline with detailed tutorials. Additionally, it provides curated genomic
resources including tissue-specific expression quantitative trait loci, ENCODE functional annotations, biological
pathways, and molecular networks, and offers interactive visualization of analytical results. Multiple computational
tools including Marker Dependency Filtering (MDF), Marker Set Enrichment Analysis (MSEA), Meta-MSEA, and
Weighted Key Driver Analysis (wKDA) can be used separately or in flexible combinations. User-defined
summary-level genomic association datasets (e.g., genetic, transcriptomic, epigenomic) related to a particular
disease or phenotype can be uploaded and computed real-time to yield biologically interpretable results, which
can be viewed online and downloaded for later use.
Conclusions: Our Mergeomics web server offers researchers flexible and user-friendly tools to facilitate integration
of multidimensional data into holistic views of disease mechanisms in the form of tissue-specific key regulators,
biological pathways, and gene networks.
Keywords: Multidimensional data integration, Omics integration, Web server, Pathway meta-analysis, Network
meta-analysis, Disease network, Key driver, GWAS, EWAS, TWAS
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Background
Human diseases are complex in nature and commonly
involve pathological changes at multiple molecular,
cellular and systemic levels [1]. The recent revolution in
genomic technologies has enabled the generation of
massive amounts of molecular data encompassing genet-
ics, transcriptomics, epigenomics, metabolomics, and
proteomics, which have become easily accessible in
public domains and private sectors. It is increasingly
recognized that analysis of individual types of data separ-
ately only reveals a fraction of the complex biology and
often misses the key players driving diseases, making
multidimensional big data integration an urgent need
[1–3]. To date, the majority of the available data integra-
tion tools focus on individual data types or analysis steps
and lack flexibility in accommodating diverse types of
genomic data. Users are typically required to turn to
multiple tools to bridge the gaps between wet lab data
and well-founded hypothesis for future experimental
exploration. Variations in performance and potential in-
compatibility between tools further amplify the difficulty
in big data integration.
To overcome these challenges, we have developed an R
package, Mergeomics (Shu et al., companion manuscript),
which has the capacity to integrate summary-level disease
association data, functional genomics (such as expression
quantitative trait loci (eQTLs) and ENCODE annotations),
biological pathways, and gene networks to identify
disease-associated gene subnetworks and key regulatory
genes. Examples of disease association data are genetic
association studies via genome-wide association studies
(GWAS) or exome sequencing, transcriptome-wide
association (TWAS) via microarray or RNA sequencing
studies, and epigenome-wide association studies (EWAS).
Mergeomics has a streamlined workflow to incorporate
multiple analysis components in modular format, allowing
flexibility in accommodating a variety of data types and
study designs.
In order to achieve this flexibility in data types and study
design, it is not feasible to deal with these diverse data
types in their native, pre-processed format. We find that
the association of markers (e.g., SNPs, genes, methylation
sites) to a phenotype from various data modalities is a
converging point that allows us to apply our strategy
across such data types as GWAS, microarray, RNA se-
quencing, DNA methylation, etc. In the context of the
current study, we use the term “association dataset” in a
broader sense by referring to the association statistics
between any omics-derived markers and a phenotype. The
applicability of the approach to various data types includ-
ing GWAS, TWAS, and EWAS has been demonstrated in
the companion paper. It is also feasible for metabolome
and proteome association datasets. In addition, the analyt-
ical pipeline can be used for datasets from any species as
long as the corresponding species-specific datasets and
information are provided. Furthermore, our pipeline offers
a meta-analysis component that can converge findings
across data types and/or species in a single analysis, as
demonstrated in the companion method paper.
To maximize the usability of Mergeomics, here we
present a user-friendly web server with full implementation
of the features in the Mergeomics R package. The web
server features four analytical modules that can correct for
dependencies between omics markers (MDF - Marker
Dependency Filtering), identify biological pathways and
networks that are enriched for disease-associated signals
from a single omics study (MSEA - Marker Set Enrichment
Analysis) or from two or more omics studies of the same
or different data types (Meta-MSEA), and identify key net-
work regulators or hubs of the disease-associated pathways
and networks (wKDA - Weighted Key Driver Analysis).
The web server is also accompanied by a detailed step-by-
step tutorial and pre-processed, commonly used datasets
such as functional genomics, pathways, and gene networks
as resources to facilitate data integration. Users have the full
flexibility to select analysis modules that best suit their
study design and data types. Summary results and inter-
active network views are displayed online and links to de-
tailed downloadable results are also available.
Implementation
The Mergeomics web server is hosted within UCLA’s
Hoffman2 High Performance Cluster as part of the
Institute for Digital Research and Education (IDRE), and
jobs are submitted using the Sun Grid Engine queuing
system. The web server front-end is written in HTML,
PHP and JavaScript and hosted through an Apache
HTTP server, which allows users to submit jobs through
web browsers (all major browsers are supported). A
400 MB file size upload restriction is imposed to ensure
reasonable compute time. User files are temporarily kept
under a randomly generated file name on the web server
during the analysis. As soon as the compute completes,
user uploaded files are deleted from the server. Submit-
ted jobs are assigned unique alphanumeric identifiers
that allow users to control access to their results. Only
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the job submitter will be given the job-specific links to
download the result files, which are kept on the web
server for 24 h to allow sufficient time to download.
Users can provide an email address (optional) if they
would like to receive notifications about their job status
and have results emailed upon task completion. Sever
traffic is monitored through the total number of hits and
the number of unique hits.
Results and discussion
Web server overview
As depicted in Fig. 1, the web server hosts three re-
source pages (HOME, TUTORIAL, and DOWNLOAD)
and four analytical modules (MDF, MSEA, Meta-MSEA,
and wKDA). The “HOME” page provides basic informa-
tion about the Mergeomics pipeline including data types
involved, overall workflow, and citation information. The
“TUTORIAL” section provides step-by-step instructions
for using the web server and detailed descriptions about
input file format requirements, analysis parameters, and
result interpretation for each analytical component. The
“DOWNLOAD” section gives users access to the standa-
lone Mergeomics R package and a wide variety of useful,
publically available genomic resources applicable in the
pipeline, including sample disease association studies,
tissue-specific eQTL studies, ENCODE resources,
knowledge-driven biochemical and signaling pathways, and
data-driven gene networks (Additional file 1: Table S1).
The four analytical modules are: 1) MDF, standing for
Marker Dependency Filtering, which corrects for depend-
encies between omics markers (e.g. correcting for linkage
disequilibrium or LD between genetic variants in GWAS),
2) MSEA, standing for Marker Set Enrichment Analysis,
that allows users to leverage multi-omics association data,
functional genomics, canonical pathways and/or data-
driven gene modules to identify causal subnetworks of
disease or traits; 3) Meta-MSEA, which performs pathway-
or network-level meta-analysis when multiple association
datasets from different studies (e.g., multiple GWAS) and/
or of different data types (e.g., GWAS and EWAS) are
available; 4) wKDA, standing for weighted key driver ana-
lysis, which maps disease associated genes to tissue-specific
gene networks to identify potential key drivers or regula-
tors of disease. We also provide an interactive network
visualization module for visualizing select key drivers and
their associated disease subnetworks.
To use the web server, users follow a streamlined
workflow (Fig. 1) by setting up the parameters and selecting
or uploading datasets necessary for each of the analytical
components. Due to the modular design, users are allowed
the flexibility to choose subsets of the analytical compo-
nents according to available datasets and specific study
design (Fig. 2). For example, if a single association dataset
(e.g., GWAS/EWAS/TWAS) is available, users can identify
the causal subnetwork and key regulatory gene of a trait or
disease using the MSEA-wKDA-Visualization workflow
(Fig. 2a). If multiple association datasets of either the same
data type or different data types are available, the Meta-
MSEA-wKDA-Visualization workflow is more appropriate
(Fig. 2b). If only groups of disease-associated genes are
available, the wKDA-Visualization workflow is sufficient to
generate the key regulators and disease subnetworks, and
users could still explore the association of the gene sets
with the same disease in other organisms or other relevant
disease types using MSEA or Meta-MSEA, if the corre-
sponding association data is available (Fig. 2c). As techno-
logical advances bring about new data types, they can be
effectively incorporated into the analysis framework of
Mergeomics. In the following sections we explain each ana-
lytical component of the Mergeomics web server in detail.
Fig. 1 Web server pipeline overview with red lines indicating cross-module interactions, green headers indicating resource pages, and teal headers
indicating analytical modules
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Marker dependency filtering (MDF)
Depending on the type of data to be analyzed in MSEA or
Meta-MSEA, an additional step may be required to correct
for any dependencies between the markers (e.g., LD
between single nucleotide polymorphisms (SNPs) in
GWAS, correlation between adjacent methylation sites,
etc.). For GWAS, we provide on-the-fly pruning of SNPs
based on HapMap3 LD information and user-defined LD
cutoffs. For other types of markers, users need to prepare
and upload the marker association files containing
independent markers. If dependency among markers is
not corrected, spurious results may be generated.
Data input
1) Association summary results between molecular
markers and a disease or phenotype as described in
the following MSEA section.
2) Gene-marker mapping file as described in the MSEA
section.
3) Marker dependency file, which describes the
pairwise relationships of the markers in the
association file.
Parameter setting
Two parameters are required for MDF: marker depend-
ency cutoff and the percentage of top markers to be
used. For GWAS, LD cutoff defines the maximum ac-
ceptable r2 values when pruning the SNPs, which is done
using the built-in MDPRUNE program of Mergeomics
pipeline. The MDPRUNE program is also downloadable
from the web server and can be run independently for
marker pruning. The percentage of top marker param-
eter is introduced to increase signal to noise ratio since
more noise tends to be present towards the weaker asso-
ciation spectrum [4]. Default parameters yield optimal
performance for GWAS based on simulation.
Result interpretation
The output of MDF contains the marker-disease associ-
ation results only for independent markers after pruning,
which can be directly used in the downstream MSEA or
meta-MSEA analysis.
Marker-set enrichment analysis (MSEA)
MSEA proceeds in the following order. Step 1: Upload
marker-level association data. Only summary level associ-
ation results featuring marker IDs and association –log10
p-values are needed. Step 2: Map marker-level association
p-values to genes based on available genomic mapping.
Step 3: Assign p-values to knowledge-driven or data-driven
gene sets in the form of pathways of gene subnetwork
modules. Step 4: Perform enrichment analysis and output
gene sets significantly enriched for disease-associated
markers. Step 5: Merge top significant gene sets into non-
overlapping supersets to reduce redundancy.
Data preparation
MSEA requires three different types of data as input,
and our web server provides a number of public datasets
and allows users to upload datasets of their interest.
1) Marker-disease association summary results
including Marker IDs and –log10 transformed
association p-values (Fig. 3a). Marker types can be
SNPs, methylation loci, transcripts, proteins,
metabolites, etc. (sample datasets provided in the
web server). Non-independent relationship between
markers should be corrected if possible (using MDF
described above).
2) Gene-marker mapping file that links genomic
markers to genes (Fig. 3b). For GWAS, the most
commonly used mapping is based on genomic
distance (e.g., 10 kb, 20 kb, 50 kb), which is provided
on the web server. Such distance mapping could be
applied to methylation sites in EWAS as well.
Fig. 2 Flexibility of Mergeomics in accommodating different datasets and study designs. a When a single disease association dataset is available,
an MSEA-wKDA-visualization flow can be utilized. b When multiple disease association datasets are available, use a Meta-MSEA then wKDA flow is
more appropriate. c When selected disease-associated genes or proteins are already identified, wKDA can be directly used. MSEA could also be
run if additional association datasets are available, allowing for association testing in other diseases or cross-species validation
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A data-driven function-based mapping is more
preferred if available. To facilitate this aspect, we
provide curated publically available functional
genomics resources from ENCODE [5] and various
tissue-specific eQTLs from numerous studies
including GTEx [6] and Muther [7] (Additional file
1: Table S1). Users can upload their own mapping
files between markers and genes.
3) Functionally related gene sets defined based on
various criteria (Fig. 3d), such as co-regulation,
shared response, co-localization on chromosomes,
or participants of specific biological processes or
signaling pathways. Typical sources of gene sets
includes canonical pathways such as Reactome [8]
and KEGG [9], coexpression modules constructed
using algorithms like weighted coexpression gene
networks analysis (WGCNA) [10], and gene
signatures from gene expression profiling studies.
We provide curated functional gene sets from these
sources on our web server (Additional file 1: Table
S1), but also allow users to upload their own gene
sets. To better annotate the gene sets in MSEA
output, the user could optionally provide a descrip-
tion file for the gene sets to specify the source of the
gene set and a detailed description of the functional
information used to group genes (Fig. 3e).
Parameter setting
The core parameter of MSEA is the permutation type for
assessing null distribution. Either marker-level permuta-
tion or gene-level permutation can be selected. Gene-level
permutation is set as default as it has higher true positive
rate, low false positive rate, and low sensitivity to variation
in other parameters (Shu et al., companion manuscript).
However, users may use the more sensitive marker-level
permutation for suggestive signals. Additional parameters
include the maximum and minimum number of genes in
gene sets, false discovery rate (FDR) cutoff to determine
significant signals, and merging criteria for overlapping
gene sets (Fig. 3c; detailed in online tutorial).
Result interpretation
On the result webpage, a summary table for the top
disease-associated gene sets at a user-defined cutoff is
generated for quick reference of the MSEA results
(Fig. 3f ). This summary table reports the gene set ID,
disease association enrichment p - value of the gene set,
FDR, gene set description, top 3 genes and top 3
markers in each gene set that contribute to the overall
enrichment signal, and the association p - values (in –
log10 format) of the markers. The detailed results of
MSEA are provided in four downloadable tables: 1)
“MSEA_modules_pval.txt”: a list of gene sets ranked by
enrichment p -values and false discovery rate (FDR). 2)
“MSEA_modules_full_results.txt”: detailed enrichment
results including enrichment p -values, number of
mapped genes and markers for each gene set, and the
density ratio which gives the ratio of unique markers
mapped to gene set divided by the total markers in the
analysis. 3) “MSEA_top_modules_details.txt”: detailed
list of genes from top gene sets (default: FDR < 25 %),
accompanied by the total number of markers, top
markers and the highest –log10 transformed association
p -value for each gene. Users could use this output to
track the origin of enrichment signals as well as to iden-
tify potentially important genes and markers in each of
the significant gene sets. 4) “MSEA_genes_details.txt”:
stores gene-related MSEA results, including enrichment
score, number of markers mapped to each gene, and
markers with top association values for each gene.
Meta-MSEA
When multiple disease association datasets are available,
Meta-MSEA can be used to conduct meta-analysis at
the pathway or network level. This function allows users
to achieve maximal power by combining results from
A
F
B C D E
Fig. 3 Screenshots showing a step-by-step overview of the MSEA module using sample data on the web server. a Association data format. b
Marker mapping data format. c Parameters. d Gene sets format. e Gene sets descriptions. f Example result summary table containing the IDs and
descriptions of the gene sets tested to be associated with the disease, the p - values, FDR values, top genes and markers with the strongest dis-
ease association within each gene set, and the strongest association scores in the form of –log10 p - values
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independent association studies of different ethnicities,
platforms or even species, while avoiding the technical
difficulties when performing meta-analysis directly on the
marker-level association data [11]. To run meta-MSEA,
users simply need to navigate to the Meta-MSEA tab, and
upload multiple datasets following the same workflow as
previously described for MSEA to generate results for
individual datasets as well as the pathway/network-level
meta-analysis results. The result files produced by Meta-
MSEA follow the same layout as MSEA.
Weighted key driver analysis (wKDA)
wKDA aims to pinpoint key regulator genes or key
drivers (KDs) of the disease related gene sets from
MSEA or meta-MSEA using gene network topology and
edge weight information. Specifically, wKDA first
screens the network for candidate hub genes. Then the
disease gene sets are overlaid onto the subnetworks of
the candidate hubs to identify KDs whose neighbors are
enriched with disease genes.
Data preparation
Two types of files are required for wKDA: 1) disease-
associated gene sets (Fig. 4a) and 2) molecular networks
(Fig. 4c). wKDA can be run as either the continuing step
of MSEA or meta-MSEA or as an independent step
(Fig. 2). If the user elects to continue wKDA from MSEA
or meta-MSEA, then the enriched gene sets from these
analyses will be used as the disease-associated gene sets.
If the user elects to run wKDA as a separate module,
they must upload their own gene sets to the web server
or they can use the pre-loaded sample gene set for test-
ing. With regards to molecular networks, wKDA sup-
ports a wide range of directed and undirected regulatory
networks. wKDA is designed to utilize edge weight infor-
mation in gene networks, which could be connection
strength or reliability measures. If no edge weight infor-
mation is available, wKDA can also operate by consider-
ing equal weights to all edges. The web server provides a
collection of tissue-specific Bayesian networks previously
constructed in human and mouse studies (Additional file
1: Table S1). There are also a large number of publicly
available network resources, such as protein-protein
interactions (PPI) [12], BioGRID [13], GeneMANIA [14]
and GIANT [15], which could be used in wKDA.
Parameter setting
Core wKDA parameters include 1) search depth, which
specifies the number of layers to expand in the network
when determining the neighboring genes of candidate
KDs for enrichment assessment, and 2) edge directional-
ity, which specifies whether to neglect edge directionality
(incoming and outgoing) or require the candidate hubs
to be upstream of neighbor genes (only outgoing) for
networks that carry directionality information (Fig. 4b).
Additional parameters are described in detail in the on-
line tutorial.
Result interpretation
Summary results of wKDA will be displayed on the web-
page (Fig. 4d), which reports top 5 KDs for each disease
gene set along with the statistics. Users could also down-
load four detailed results files: 1) “wKDA_kd_pvalues.txt”,
a summary table of all KDs ranked by p -values and FDR;
2) “wKDA_kd_full_results.txt”, providing detailed statistics
on all KDs identified; 3) “wKDA_kd_tophits.txt”, p-value
summary table for only the top KDs for each disease gene
set. 4) “wKDA_hub_structure.txt”, specifying hub-cohub
A
D
B C
Fig. 4 Screenshots showing a step-by-step overview of the wKDA module using sample data on the web server. a Gene set format. b Parameters.
c Network format. d Example result summary table containing the IDs of the disease associated gene sets, their KDs, p - values and FDRs of the
KDs, gene counts of KD subnetworks, and fold enrichment of the KD subnetworks for disease genes
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relationship. The co-hub structure is useful to group KDs
with highly overlapping network topology, and to retrieve
list of independent KDs for more efficient prioritization.
Additionally, wKDA provides Cytoscape-ready files that
can be used in Cytoscape [16] for a more customized
visualization than the included web-based network
visualization module.
Network visualization
Our web server provides a convenient module to allow
users visualize top KDs and subnetworks using Cytoscape
Web v0.8 [17]. The top 5 KDs for each disease gene set
from wKDA will be automatically visualized, as exemplified
in Fig. 5a. The visualization is interactive so that users can
make real-time changes such as zooming in on a node of
interest by only considering that particular subnetwork
(Fig. 5b) or by filtering a subnetwork based on the edge
weight information (Fig. 5c), as detailed in the tutorial page.
Application example
As an illustration of our web server’s workflow and
analysis results, we applied the Mergeomics web server
to a publically available low-density lipoprotein (LDL)
GWAS dataset from the GLGC consortium [18]. All files
mentioned within this section are provided as example
files on the web server. To correct for LD between
Fig. 5 Screenshots of the network visualization module output generated by the default sample files in the wKDA module. a Overview of a
network comprised of top KDs for LDL-associated gene sets, with 5 KDs for each gene set displayed. KDs are depicted as diamond nodes and
node colors indicating gene set membership. b Focused subnetwork view of key driver of interest Fasn when filtering the network in (a) by
submitting a “Fasn” query or right clicking the node. c The network can be filtered to display only nodes with edge weights higher than a certain
threshold: 4.0 in this case
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SNPs, we used the MDF analysis module and the follow-
ing input files: the GLGC LDL GWAS summary statistics
(SNPs, −log10 p - values), SNP-gene mapping based on
50 kb chromosomal distance, and the Hapmap CEU LD
file containing SNPs with r2 > 0.7 as the Marker Depend-
ency file. We also filtered the GWAS loci by only consider
the top 50 % SNPs ranked by p - values to reduce random
noise from the weaker association spectrum.
After correction for marker-dependency using MDF, the
resulting association and mapping files were used directly as
input for MSEA (Fig. 3a-b) using gene permutation and de-
fault setting for the other parameters (Fig. 3c), to test for en-
richment for canonical pathways collected from KEGG,
Biocarta and Reactome databases (Fig. 3d-e). Upon comple-
tion of MSEA, a summary table was produced which details
the top pathways ranked by FDR along with descriptions of
the pathways and top associated genes and SNPs in each
pathway. As exemplified in Fig. 3f, “Metabolism of lipids
and lipoproteins”, “biosynthesis of unsaturated fatty acids”,
and “terepenoid backbone biosynthesis” were three of the
top pathways identified among others. APOC2, APOE, and
LDLR were listed as the top associated genes in the “metab-
olism of lipids and lipoproteins” pathway, and their corre-
sponding SNPs were also provided in the summary table.
Links to detailed result tables were also displayed for file
download. Furthermore, these top pathways were checked
for overlaps and merged if significant overlaps in gene mem-
bership between pathways were identified. A summary table
of the merged pathways was also displayed (not shown).
To identify potential KDs and subnetworks for the LDL-
associated pathways, the merged pathways were used dir-
ectly as input for wKDA (Fig. 4a). wKDA was run using
default parameters (Fig. 4b) and a liver Bayesian network
(Fig. 4c). Upon completion, a summary table is produced
(Fig. 4d) which lists the top 5 KDs for each merged
module and information about their local subnetwork
structure. For example, Fasn was a KD for the Metabolism
of Lipids and Lipoproteins pathway. Links to detailed
result tables were also displayed for file download.
The wKDA results can be viewed directly using the
interactive visualization feature, which by default illus-
trates the top 5 KDs for each gene set and their local
subnetworks with disease genes highlighted (Fig. 5a).
The networks can be filtered by selecting a particular
KD of interest to focus on (Fig. 5b) or by removing
edges below an edge weight cutoff to focus on high
confidence network connections (Fig. 5c). To facilitate
further customization of network views, Cytoscape-
ready files can be downloaded for external visualization.
Conclusions
We have implemented the Mergeomics pipeline as a user-
friendly, publicly available web server that can facilitate
multidimensional omics data integration to expedite novel
discoveries. The web server also pre-populates a wide
range of publically available data sources. Users can apply
the pipeline to their own data in conjunction with any
preloaded data to identify disease-associated pathways,
gene networks, and key regulators. The web server in-
cludes step-by-step tutorials, examples and visualization
tools in a web-based platform. The flexibility of the web
server to accommodate various omics data types and to
conduct pathway and network-level meta-analysis of
multiple studies of different design will boost our ability
to integrate big data.
Additional file
Additional file 1: Table S1. List of public datasets available for access
in the Mergeomics web server. (DOCX 128 kb)
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